跳至内容
当前位置: 首页 产品中心 分析试剂 生物试剂 Factor X (cleaved Ala41) antibody|GTX86931|100μg
Factor X (cleaved Ala41) antibody|GTX86931|100μg
图片仅供参考,具体产品以实物为准!

Factor X (cleaved Ala41) antibody|GTX86931|100μg

GTX86931
Factor X (cleaved Ala41) antibody
¥ 5300.0
¥ 5300.0
100μg
萘析精选
见详情
− +
0
Factor X (cleaved Ala41) antibody介绍:

产品名称:
Factor X (cleaved Ala41) antibody
别名:
F10 , FX , FXA , coagulation factor X , Factor X
反应种属:
Human
宿主来源:
Rabbit
实验应用:
WB
靶标/特异性:
Factor X (cleaved Ala41) antibody detects endogenous levels of fragment of activated FA10 resulting from cleavage adjacent to Ala41.
同种型:
IgG
免疫原:
The antiserum was produced against synthesized peptide derived from human Factor X (22-71).
克隆性:
Polyclonal
克隆号:
纯化方式:
Purified by antigen-affinity chromatography
偶联:
Unconjugated
产品浓度:
Batch dependent (Please refer to the vial label for the specific concentration.)
保存温度:
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
运输温度:
4°C
预期分子量:
55
产品形式:
Liquid
存储溶液:
PBS, 150mM NaCl, 50% Glycerol, 0.02% Sodium azide.
生产商:
GeneTex
功能与背景:
This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]

本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。

暂无标准解读内容
暂无常见问题内容